Topical Mecamylamine for Diabetic Macular Edema

American Journal of Ophthalmology

Volumn 149, Issue 5, 2010, Pages

  Campochiaro, Peter A ^a   Shah, Syed Mahmood ^a   Hafiz, Gulnar ^a   Heier, Jeffery S ^b   Lit, Eugene S ^c   Zimmer Galler, Ingrid ^a   Channa, Roomasa ^a   Nguyen, Quan Dong ^a   Syed, Beena ^a   Do, Diana V ^a   Lu, Lili ^a   Monk, James ^d   Cooke, John P ^e   Kengatharan, M Ken ^d   Hsu, Henry H ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^c East Bay Retina Consultants   (United States)

^d CoMentis Inc ^*  (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MECAMYLAMINE; NICOTINIC RECEPTOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOTHELIUM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETINA FOVEA; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY;

EID: 77950863290     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.12.005     Document Type: Article

References (22)

1. D'hoedt D., and Bertrand D. Nicotinic acetylcholine receptors: an overview on drug discovery. Expert Opin Ther Targets 13 (2009) 395-411
2. Girod R., Crabtree G., Ernstrom G., et al. Heteromeric complexes of alpha 5 and/or alpha 7 subunits. Effects of calcium and potential role in nicotine-induced presynaptic facilitation. Ann N Y Acad Sci 868 (1999) 578-590
3. Fucile S. Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35 (2004) 1-8
4. Eusebi F., Molinaro M., and Zani B.M. Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes. J Cell Biol 100 (1985) 1339-1342
5. Huganir R.L., Delcour A.H., Greengard P., and Hess G.P. Phosphorylation of the nicotinic acetylcholinergic receptor regulates its rate of desensitization. Nature 321 (1986) 1986
6. Pontieri F.E., Tanda G., Orzi F., and DiChiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382 (1996) 255-257
7. Villablanca A.C. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84 (1998) 2089-2098
8. Heeschen C., Jang J.J., Weis M., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7 (2001) 833-839
9. Milner P., Kirkpatrick K.A., Ralevic V., Toothill V., Pearson J., and Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc Biol Sci 241 (1990) 245-248
10. Suner I.J., Espinosa-Heidmann D.G., Marin-Castano M.E., Hernandez E.P., Pereira-Simon S., and Cousins S.W. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45 (2004) 311-317
11. Kiuchi K., Matsuoka M., Wu J.C., et al. Mecamylamine suppresses basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci 49 (2008) 1705-1711
12. Abbruscato T.J., Lopez S.P., Mark K.S., Hawkins B.T., and Davis T.P. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 91 (2002) 2525-2538
13. Cooke J.P., and Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 36 (2004) 33-40
14. Stone C.A., Torchiana M.L., Navarro A., and Beyer K.H. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine. J Pharmaocol 117 (1956) 169-183
15. Shytle R.D., Penny E., Silver A.A., Goldman J., and Sanberg P.R. Mecamylamine (Inversine): an old antihypertensive with new research directions. J Hum Hyperten 16 (2002) 452-457
16. Shytle R.D., Silver A.A., Lukas R.J., Newman M.B., Sheehan D.V., and Sanberg P.R. Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 7 (2002) 525-535
17. Rose J.E., Behm F.M., and Westman E.C. Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Exp Clin Psychopharmaocol 6 (1998) 331-343
18. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
19. Chan A., Duker J.S., Ko T.H., Fujimoto J.G., and Schuman J.S. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol 124 (2006) 193-198
20. Wu J.C.F., Chruscinski A., De Jesus Perez V.A., et al. Cholinergic modulation of angiogenesis: role of the alpha 7 nictotinic acetylcholine receptor. J Cell Biochem 108 (2009) 433-446
21. Nguyen Q.D., Tatlipinar S., Shah S.M., et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 142 (2006) 961-969
22. Nguyen Q.D., Shah S.M., Heier J.S., et al. Primary end point (six months) results of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) Study. Ophthalmology 116 (2009) 2175-2181